首页> 外文期刊>Regulatory peptides. >Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats.
【24h】

Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats.

机译:脑室内给予NPY-Y1受体拮抗剂1229U91对雌性大鼠对急性和慢性中度胰岛素诱导的低血糖的高吞噬和血糖反应的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Neuropeptide Y (NPY) Y1 receptors are implicated in CNS regulation of food intake, but their role in hypoglycemic hyperphagia remains unclear. The present studies utilized a pharmacological approach to investigate the hypothesis that NPY acts via Y1 receptor-dependent mechanisms to regulate feeding and blood glucose profiles during intermediate insulin-induced hypoglycemia. Groups of ovariectomized, estradiol benzoate-treated female rats were injected subcutaneously with one or four doses of neutral protamine Hagedorn insulin (NPH), on as many days, or with diluent alone. Before final treatments on day four, the animals were pretreated by intracerebroventricular (icv) delivery of the NPY Y1 receptor antagonist, 1229U91, or the vehicle, artificial cerebrospinal fluid (acsf). Food intake during acute hypoglycemia was significantly diminished between t(o) and +2 h in animals pretreated with the Y1 receptor antagonist versus vehicle. Administration of 1229U91 prior to the fourth of four NPH doses suppressed hypoglycemic hyperphagia over a relatively longer interval, e.g. 4 h, after t(o) relative to the acute insulin group. Blood glucose levels after a single NPH injection were similar in acsf- and antagonist-pretreated rats at +2, +4, and +6 h, but were lower at +9 h in the latter group. Pretreatment with 1229U91 did not modify glucose profiles between +2 and +9 h after multiple dosing with NPH, but prevented recovery from hypoglycemia at +12 h. The present results show that central NPY Y1 receptor antagonism inhibits hypoglycemic hyperphagia, and that this suppressive effect on feeding was of greater duration during recurring hypoglycemia. The data also show that Y1 receptor blockade decreases glycemic responses to both single and serial NPH dosing, albeit at different post-injection time points. The current studies support the view that NPY Y1 receptors function within central neural pathways that govern feeding and glycemic responses to intermediate-acting insulin, and that Y1 receptor-mediated stimulation of food intake may habituate in a positive manner to repetitive insulin-induced hypoglycemia. Further research is needed to evaluate the impact of chronic insulin-induced hypoglycemia on neuropeptide Y neurotransmission and Y1 receptor expression within regulatory circuitries that control food intake and glucostasis.
机译:神经肽Y(NPY)Y1受体与中枢神经系统对食物摄入的调节有关,但它们在降血糖亢进中的作用仍不清楚。本研究利用一种药理学方法研究了NPY在中度胰岛素诱导的低血糖期间通过Y1受体依赖性机制调节摄食和血糖分布的假设。在数天之内,皮下注射成组的经卵巢切除的雌二醇苯甲酸酯治疗的雌性大鼠皮下注射一剂或四剂中性鱼精蛋白Hagedorn胰岛素(NPH),或者单独使用稀释剂。在第四天进行最终治疗之前,通过脑室内(icv)递送NPY Y1受体拮抗剂1229U91或媒介物人工脑脊髓液(acsf)对动物进行预处理。在用Y1受体拮抗剂相对于媒介物预处理的动物中,急性低血糖症期间的食物摄入量在t(o)和+2 h之间显着减少。在四个NPH剂量中的第四个剂量之前给予1229U91可以在相对较长的时间间隔内抑制降血糖亢进,例如相对于急性胰岛素组t(o)后4小时。在Acsf和拮抗剂预处理的大鼠中,单次NPH注射后的血糖水平在+ 2,+ 4和+6 h时相似,但在+9 h时较低。使用NPH多次给药后,用1229U91预处理不会在+2至+9 h之间改变葡萄糖谱,但阻止了+12 h从低血糖中恢复。目前的结果表明,中枢NPY Y1受体拮抗作用抑制了低血糖吞噬,并且这种对进食的抑制作用在复发性低血糖期间持续时间更长。数据还显示,尽管在不同的注射后时间点,Y1受体阻滞也会降低对单次和连续NPH剂量的血糖反应。当前的研究支持以下观点:NPY Y1受体在中枢神经通路中起作用,该通路控制对中效胰岛素的进食和血糖反应,并且Y1受体介导的食物摄取刺激可能以积极的方式习惯于重复性胰岛素诱导的低血糖症。需要进一步的研究来评估慢性胰岛素诱发的低血糖对控制食物摄入和糖代谢的调节回路中神经肽Y神经传递和Y1受体表达的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号